Eli Lilly previously said that phase three study was expected to finish in February 2026 ... Lilly's weight loss shot Zepbound and diabetes drug Mounjaro, mimics two of the hormones, GLP ...

Wegovy sales increased by more than 100% over 2024. But that wasn’t enough to satiate analysts who want to know why Novo Nordisk can’t access more patients, particularly in the U.S.

Eli Lilly has ... and then selling the three fill-and-finish facilities in the US, Belgium, and Italy to Novo Nordisk for $11 billion. The issue was also alluded to by Lilly’s chief financial ...